DIGOXIN-VERAPAMIL INTERACTION - REDUCTION OF BILIARY BUT NOT RENAL DIGOXIN CLEARANCE IN HUMANS

被引:52
作者
HEDMAN, A
ANGELIN, B
ARVIDSSON, A
BECK, O
DAHLQVIST, R
NILSSON, B
OLSSON, M
SCHENCKGUSTAFSSON, K
机构
[1] HUDDINGE UNIV HOSP, KAROLINSKA INST, DEPT MED, S-14186 HUDDINGE, SWEDEN
[2] HUDDINGE UNIV HOSP, KAROLINSKA INST, DEPT RADIOL, METAB UNIT, S-14186 HUDDINGE, SWEDEN
[3] KAROLINSKA HOSP, DEPT CLIN PHARMACOL, S-10401 STOCKHOLM 60, SWEDEN
[4] KAROLINSKA HOSP, DEPT MED, S-10401 STOCKHOLM 60, SWEDEN
关键词
D O I
10.1038/clpt.1991.26
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interaction between digoxin and verapamil was studied in six patients (mean age +/- SD, 61 +/- 5 years) with chronic atrial fibrillation. The effects of adding verapamil (240 mg/day) on steady-state plasma concentrations and renal and biliary clearances of digoxin were studied in a crossover manner. The biliary clearance of digoxin was determined by a duodenal perfusion technique. Verapamil induced a 44% increase in steady-state plasma concentrations of digoxin, from 0.80 +/- 0.24 to 1.15 +/- 0.40 nmol/L (p < 0.01). The biliary clearance of digoxin decreased by 43%, from 187 +/- 89 to 101 +/- 55 ml/min (p < 0.05), in the presence of verapamil, whereas the renal clearance was unaffected (153 +/- 31 versus 173 +/- 51 ml/min; difference not significant). Our results indicate that the main inhibitory effect of verapamil on digoxin elimination is on the biliary route.
引用
收藏
页码:256 / 262
页数:7
相关论文
共 37 条
[1]   DILTIAZEM INCREASES STEADY-STATE DIGOXIN SERUM LEVELS IN PATIENTS WITH CARDIAC DISEASE [J].
ANDREJAK, M ;
HARY, L ;
ANDREJAK, MT ;
LESBRE, JP .
JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (12) :967-970
[2]   QUINIDINE REDUCES BILIARY CLEARANCE OF DIGOXIN IN MAN [J].
ANGELIN, B ;
ARVIDSSON, A ;
DAHLQVIST, R ;
HEDMAN, A ;
SCHENCKGUSTAFSSON, K .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1987, 17 (03) :262-265
[3]   CEFTRIAXONE - RENAL AND BILIARY-EXCRETION AND EFFECT ON THE COLON MICROFLORA [J].
ARVIDSSON, A ;
ALVAN, G ;
ANGELIN, B ;
BORGA, O ;
NORD, CE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 10 (03) :207-215
[4]   ABSORPTION OF ORALLY ADMINISTERED [12 ALPHA-H-3 ]DIGOXIN IN MAN [J].
BEERMANN, B ;
HELLSTROM, K ;
ROSEN, A .
CLINICAL SCIENCE, 1972, 43 (04) :507-+
[5]   INTERACTION BETWEEN DIGOXIN AND CALCIUM-ANTAGONISTS AND ANTI-ARRHYTHMIC DRUGS [J].
BELZ, GG ;
DOERING, W ;
MUNKES, R ;
MATTHEWS, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (04) :410-417
[6]  
BELZ GG, 1981, LANCET, V1, P844
[7]   NO INCREASE IN SERUM DIGOXIN CONCENTRATION WITH HIGH-DOSE DILTIAZEM [J].
BODEN, WE ;
MORE, G ;
SHARMA, S ;
BOUGH, EW ;
KORR, KS ;
YOUNG, PM ;
SHULMAN, RS .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (03) :425-428
[8]  
BROWN DD, 1976, CLIN PHARMACOL THER, V20, P395
[9]  
CALDWELL JH, 1976, CLIN PHARMACOL THER, V19, P410
[10]   INTESTINAL SECRETION OF DIGOXIN IN THE RAT - AUGMENTATION BY FEEDING ACTIVATED-CHARCOAL [J].
CALDWELL, JH ;
CALDWELL, PB ;
MURPHY, JW ;
BEACHLER, CW .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 312 (03) :271-275